Back in 2005 researchers from Madrid’s Complutense University and the Cajal Institute, published an article in the Journal of Neuroscience showing that  a synthetic cannabinoid appeared to reduce brain inflammation in Alzheimer’s.  Reduction of this inflammation helps to prevent the mental decline associated with this disease.